NDC 0069-0296

Talzenna

Talazoparib

Talzenna is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Talazoparib Tosylate.

• Product ID: 0069-0296_054b5fec-a4ea-4bb5-8222-a6c931557ee3
• NDC: 0069-0296
• Product Type: Human Prescription Drug
• Proprietary Name: Talzenna
• Generic Name: Talazoparib
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2018-10-26
• Marketing Category: NDA / NDA
• Application Number: NDA211651
• Labeler Name: Pfizer Laboratories Div Pfizer Inc
• Substance Name: TALAZOPARIB TOSYLATE
• Active Ingredient Strength: 0 mg/1
• Pharm Classes: Poly(ADP-Ribose) Polymerase Inhibitor [EPC],Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0069-0296-30

30 CAPSULE in 1 BOTTLE (0069-0296-30)

• Marketing Start Date: 2018-10-26
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0069-0296-30 [00069029630]

Talzenna CAPSULE

• Marketing Category: NDA
• Application Number: NDA211651
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2018-10-26

Drug Details

Active Ingredients

Ingredient	Strength
TALAZOPARIB TOSYLATE	.25 mg/1

OpenFDA Data

• SPL SET ID: f2423edd-6d24-495c-aec1-c2f457f08d9a
• Manufacturer:
  • Pfizer Laboratories Div Pfizer Inc
• UNII:
  • 02WK9U5NZC
• RxNorm Concept Unique ID - RxCUI:
  • 2099954
  • 2099956
  • 2099946
  • 2099952

Pharmacological Class

• Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
• Poly(ADP-Ribose) Polymerase Inhibitors [MoA]

NDC Crossover Matching brand name "Talzenna" or generic name "Talazoparib"

NDC	Brand Name	Generic Name
0069-0296	Talzenna	talazoparib
0069-1195	Talzenna	talazoparib
0069-1501	Talzenna	talazoparib
0069-1751	Talzenna	talazoparib
46014-0296	Talzenna	talazoparib
46014-1195	Talzenna	talazoparib
63539-295	Talzenna	talazoparib